Report cover image

Monkeypox Treatment Market

Published Apr 10, 2025
Length 290 Pages
SKU # FMARI20575947

Description

Monkeypox Treatment: Global Industry Analysis 2020-2024 and Opportunity Assessment 2025-2035

A recent market study published by FMI on Monkeypox Treatment offers a global industry analysis for 2020-2024 and opportunity assessment for 2025-2035. The study offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical and current growth parameters, the growth prospects of the market are obtained with maximum precision.

Market Segmentation

By Treatment Type:
  • Prophylactic- Vaccines
  • Therapeutic
By Route of Administration:
  • Oral
  • Injectable
By Distribution Channel:
  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies
By Region:
  • North America
  • Latin America
  • East Asia
  • South Asia & Pacific
  • Eastern Europe
  • Western Europe
  • Middle East & Africa
Report Chapters

Executive Summary

The executive summary of the Monkeypox Treatment includes the global market outlook, demand side trends, supply side trends and also include FMI analysis and recommendations of Monkeypox Treatment.

Chapter 01 - Market Overview

Readers can find the detailed segmentation and definition of the Monkeypox Treatment in this chapter, which will help to understand basic information about Monkeypox Treatment. This section also highlights the market scope, taxonomy and limitations which help the reader understand the market coverage of Monkeypox Treatment report.

Chapter 02 - Market Background

This chapter includes detailed analysis of the By Treatment Type processing methods overview, consumer buying patterns & tendencies and policy developments and regulatory scenario. It also includes in depth analysis of macro-economic factors and covers topics like global GDP growth outlook, global industry value added, personal consumption, expenditures, modern trade penetration and consumer price indices. The chapter also covers forecast factors - relevance & impact, value chain analysis and market dynamics (drivers, restraints and opportunities) to better understand the market.

Chapter 03 - Global Monkeypox Treatment Demand Analysis 2020-2024 and Forecast, 2025-2035

The chapter include historical market value (XX) analysis (2020-2024) and current and future market value (USD 295.85 million) and volume (10%) projections (2025-2035). The projections are based on the Y-O-Y growth trend analysis and absolute $ opportunity analysis country of operation.

Chapter 04 - Global Monkeypox Treatment - Pricing Analysis

Based on By Treatment Type, the pricing analysis chapter include Regional pricing analysis (USD/MT), global average pricing analysis benchmark, and key factors impacting the pricing.

Chapter 05 - Global Monkeypox Treatment Analysis 2020-2024 and Forecast 2025-2035, By Treatment Type

Based on By Treatment Type, Monkeypox Treatment is segmented into Prophylactic- Vaccines, Therapeutic. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Treatment Type.

Chapter 06 - Global Monkeypox Treatment Analysis 2020-2024 and Forecast 2025-2035, By Route of Administration

Based on By Route of Administration, Monkeypox Treatment is segmented into Oral, Injectable. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Route of Administration.

Chapter 07 - Global Monkeypox Treatment Analysis 2020-2024 and Forecast 2025-2035, By Distribution Channel

Based on By Distribution Channel, Monkeypox Treatment is segmented into Retail Pharmacies, Hospital Pharmacies, Online Pharmacies. This section also offers market attractiveness analysis based on By Distribution Channel. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Distribution Channel.

Chapter 08 - Monkeypox Treatment Analysis 2020-2024 and Forecast 2025-2035, By Region

Based on By Region, Monkeypox Treatment is segmented into North America, Latin America, Europe, East Asia, South Asia, Oceania and Middle East & Africa. This section also offers market attractiveness analysis based on By Region. Readers can also find value forecast and Y-o-Y growth comparison for all above mentioned By Region.

Chapter 09 - North America Monkeypox Treatment Analysis 2020-2024 and Forecast 2025-2035

This chapter includes a detailed analysis of the growth of the Monkeypox Treatment in the North American region, along with a country-wise assessment that includes the US and Canada. Readers can also find regional trends, regulations, and market growth based on different segment and countries in the North America region.

Chapter 10 - Latin America Monkeypox Treatment Analysis 2020-2024 and Forecast 2025-2035

This chapter includes a detailed analysis of the growth of Monkeypox Treatment in the Latin America region, along with a country-wise assessment that includes the Brazil, Mexico, Chile, Argentina, Peru and Rest of Latin America. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Monkeypox Treatment in the Latin America region.

Chapter 11 - Europe Monkeypox Treatment Analysis 2020-2024 and Forecast 2025-2035

This chapter includes a detailed analysis of the growth of Monkeypox Treatment in the European region, along with a country-wise assessment that includes the Germany, Italy, France, U.K., Spain, Russia, Nordic, Benelux and Rest of Europe. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Monkeypox Treatment in the regional market.

Chapter 12 - East Asia Monkeypox Treatment Analysis 2020-2024 and Forecast 2025-2035

This chapter includes a detailed analysis of the growth of Monkeypox Treatment in the East Asia region, along with a country-wise assessment that includes the China, Japan, and South Korea. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Monkeypox Treatment in the regional market.

Chapter 13 - South Asia Monkeypox Treatment Analysis 2020-2024 and Forecast 2025-2035

This chapter includes a detailed analysis of the growth of Monkeypox Treatment in the South Asia region, along with a country-wise assessment that includes the India, Indonesia, Malaysia, Thailand, and Rest of South Asia. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Monkeypox Treatment in the regional market.

Chapter 14 - Middle East and Africa Monkeypox Treatment Analysis 2020-2024 and Forecast 2025-2035

This chapter includes a detailed analysis of the growth of Monkeypox Treatment in the MEA region, along with a country-wise assessment that includes the GCC Countries, South Africa, North Africa, Turkey and Rest of MEA. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Monkeypox Treatment in the regional market.

Chapter 15 - Key Countries Monkeypox Treatment Analysis 2020-2024 and Forecast 2025-2035

This chapter offers insights into how the Monkeypox Treatment is expected to grow in major countries globally.

Chapter 16 - Market Structure Analysis- Global Assessment

This chapter includes company dashboard, industry structure analysis by tier of companies, 2024E, company share analysis of top players, 2024E, and competition benchmarking- matrix.

Chapter 17 - Competition Deep Dive (Tentative List)

This chapter includes company overview, By Treatment Type portfolio of companies, profitability by market segments, sales footprint, SWOT analysis and strategy overview of the companies being studied in the report. Some of the market players featured in the report are SIGA Technologies Inc., Chimerix, Inc., Bavarian Nordic, Sanofi SA, Emcure Pharmaceuticals, Jinan Jinda Pharmaceutical Chemistry Co., Ltd., Emergent Pharmaceuticals, Gilead Sciences, Inc., Hetero, Piramal Pharma Solutions

Chapter 18 - Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the Monkeypox Treatment report.

Chapter 19 - Research Methodology

This chapter helps readers understand the research methodology followed to obtain various conclusions, as well as important qualitative and quantitative information, on Monkeypox Treatment.

Table of Contents

290 Pages
Executive Summary
Industry Introduction, including Taxonomy and Market Definition
Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
Global Market Demand Analysis 2020 to 2024 and Forecast 2025 to 2035, including Historical Analysis and Future Projections
Pricing Analysis
Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035
By Treatment Type
By Route of Administration
By Distribution Channel
Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Treatment Type
Prophylactic- Vaccines
Therapeutic
Tecovirimat
Brincidofovir
Cidofovir
Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Route of Administration
Oral
Injectable
Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Distribution Channel
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Region
North America
Latin America
East Asia
South Asia & Pacific
Eastern Europe
Western Europe
Middle East & Africa
North America Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
Latin America Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
East Asia Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
South Asia & Pacific Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
Eastern Europe Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
Western Europe Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
Middle East & Africa Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
Sales Forecast 2025 to 2035 by By Treatment Type, By Route of Administration, and By Distribution Channel for 30 Countries
Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
Company Profile
SIGA Technologies Inc.
Chimerix, Inc.
Bavarian Nordic
Sanofi SA
Emcure Pharmaceuticals
Jinan Jinda Pharmaceutical Chemistry Co., Ltd.
Emergent Pharmaceuticals
Gilead Sciences, Inc.
Hetero
Piramal Pharma Solutions
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.